Floriane Courbard-Nicolle

Floriane Courbard-Nicolle has a comprehensive work history in regulatory affairs. Floriane is currently serving as the Director of Global Regulatory Strategy at Sarepta Therapeutics since March 2022. Prior to this, they held the position of Associate Director of Global Regulatory Strategy at the same company from March 2021 to February 2022. From November 2020 to March 2021, they worked as the Associate Director of International Regulatory Affairs.

Before joining Sarepta Therapeutics, Floriane gained significant experience at Allergan, starting in 2015. Floriane'sroles at Allergan include Associate Director of Regulatory Affairs for EU Ophthalmology & Dermatology TAs from April 2020 to November 2020, Senior Manager of Regulatory Affairs from June 2018 to March 2020, and Regulatory Affairs Manager from September 2015 to May 2018.

Additionally, Floriane worked at Actavis plc (now Allergan plc) as a Strategy Manager in Regulatory Affairs from March 2015 to August 2015. Prior to this, they served as a Regulatory Affairs Executive at Forest Laboratories from January 2014 to March 2015.

Floriane started their career as a Regulatory Affairs Officer at Arrow, part of the Watson Pharmaceutical Group, from April 2012 to June 2013. Floriane also gained experience as a Regulatory Affairs Intern at Glenmark Generics Ltd. from March 2011 to April 2012.

Floriane Courbard-Nicolle completed their Master's degree in International Drug Development and Registration from Paris-Sud University (Paris XI) during 2009-2011. Prior to that, they pursued Pharmaceutical Studies at the same university from 2005 to 2011. Currently, they are pursuing a Doctor of Pharmacy (Pharm.D.) degree in Trachea transplantation and infection risks from Paris-Sud University (Paris XI) since 2014.